Latest news with #Cell&GeneMeetingontheMed

Associated Press

Coave Therapeutics to Attend Upcoming Conferences

Paris, France, April 9, 2025 – Coave Therapeutics ('Coave'), a company pioneering the future of genetic medicines, announces that members of its leadership team will be attending the following industry conferences: Cell & Gene Meeting on the Med – April 15-17 Rome, Italy CEO Rodolphe Clerval will be participating in a panel discussion – Science slam: Ocular Indications – on April 15 at 13:45 CEST Rodolphe Clerval will also give a Company Presentation on April 15 at 15:00 CEST ARVO (Association for Research in Vision and Ophthalmology) – May 4-8 Salt Lake City, UT, USA BioEquity Europe – May 12-14 Bruges, Belgium ASGCT (American Society of Gene and Cell Therapy) – May 13-17 New Orleans, LA, USA *** About Coave Therapeutics Coave Therapeutics is a genetic medicine company pioneering the development of innovative solutions to enhance the precision, safety, efficacy and manufacturability of genetic medicines. With its proprietary ALIGATER™ platform, Coave is at the forefront of addressing challenges in gene therapy delivery to extra-hepatic tissues, creating a robust pipeline targeting CNS, neuromuscular and eye diseases. and follow us on LinkedIn. Coave Therapeutics Rodolphe Clerval, CEO MEDiSTRAVA Sylvie Berrebi, Mark Swallow